Developing Medicase, a connected smart-dispensing system for automated medication dispensing and therapy monitoring
HEALIUM (Healium Solutions)
Lausanne, CH · Ecublens, CHNew on Amplifa
About Healium
Healium is a Swiss medtech start-up based in Lausanne that improves medication adherence in patients with complex and chronic treatments. The flagship product Medicase is a connected, portable medication dispensing device that holds up to ten medications in all formats via bulk filling, automatically portions them and dispenses the exact dose at the push of a button. Integrated sensors automatically detect medication intake and log it in real time in a companion app for relatives, caregivers and physicians, including intelligent escalation for missed doses and automatic report generation. The system combines IoT hardware with caregiver software while preserving patient autonomy. Prototypes were validated with CHUV, Unisanté and H4; a pilot with the Swiss homecare network AVASAD is agreed. Healium is an EPFL spin-off and is preparing certification as a Class IIa medical device.
- Site
- Lausanne, Switzerland
- Processes
- Smart Medication Dispensing (Medicase), Caregiver App with Remote Monitoring, Automatic Intake Detection, Intelligent Escalation for Missed Doses, Report Generation for Physicians
- Materials
- IoT Hardware (Medicase), Caregiver Software/App
- Certificates
- CE Class IIa (in preparation)
- Founded
- 2024
- Employees
- 2–10
- Industries
- Medtech, Digital Health, Home Care, Nursing Care, Chronic Diseases
- 01
Engineering & Product Design
- 02
R&D and Prototype Building
- 03
Usability Testing with Caregivers and Patients
- 04
Industrialization (Design for Manufacturing, Risk Analysis)
- 05
Medical Device Certification
- 06
Pilot Deployment
- 07
Software Platform & Remote Monitoring
Technology & Development
IoT Hardware (Medicase)
Connected dispensing device with embedded sensors for automatic intake detection.
Caregiver Software/App
Mobile app and dashboard for remote monitoring, escalation and report generation.
Locations
Lausanne
CHHeadquarters
Ecublens
CHSite (Dealroom HQ, EPFL environment)
Inside the production
Industries
Additional services
Reference customers
Quality & Regulatory Development
Healium is developing Medicase as a Class IIa medical device; CE certification has been initiated. Industrialization includes risk analysis, test protocols and formative usability studies with caregivers and patients.
| Evidence | Lausanne |
|---|---|
| CE Class IIa (in preparation) |
History
- 2024
Healium founded by Moncef Assa and Victor Li.
- 2025
Validation with CHUV, Unisanté and H4; 7 grants, 2 patents pending, CE Class IIa certification initiated; CHF 400k pre-seed targeted.
- 2025
Future of Health Grant Level 2 (EPFL Innovation Park and CSS).
- 2026
EPFL spin-off; pilot with AVASAD; LOIs with ASFAM and 2 distributors; prototype with 10 compartments planned (Q2 2026), final industrial design Q4 2026.
- 2027
Pilot deployment planned.